Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

Academic Editor

  • Jaume Sastre-Garriga

Download

  • [1]Afentou N, Jarl J, Gerdtham UG, Saha S. Economic Evaluation of Interventions in Parkinson’s Disease: A Systematic Literature Review. Movement Disorders Clinical Practice. 2019; 6: 282–290. https://doi.org/10.1002/mdc3.12755.

  • [2]Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2022. Disponible en: https://vizhub.healthdata.org/gbd-results/ (Accedido: 23 Febrero 2025).

  • [3]Cuenca MCS, Paz EC. Envejecimiento y dependencia en España: Un enfoque de políticas públicas. Revista Central de Sociología. 2024; 18: 8–31.

  • [4]Schröter N, Sajonz BEA, Jost WH, Rijntjes M, Coenen VA, Groppa S. Advanced therapies in Parkinson’s disease: an individualized approach to their indication. Journal of Neural Transmission. 2024; 131: 1285–1293. https://doi.org/10.1007/s00702-024-02773-3.

  • [5]Constantin VA, Szász JA, Dulamea AO, Valkovic P, Kulisevsky J. Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease. Neuropsychiatric Disease and Treatment. 2023; 19: 1959–1972. https://doi.org/10.2147/NDT.S422717.

  • [6]García-Fernández C, Vargas-Mendoza AK, López-López B, Blázquez-Estrada M, Suárez-San Martín ME. Nocturnal continuous subcutaneous infusion of apomorphine in advanced Parkinson’s disease: a series of 37 cases. Revista De Neurologia. 2024; 79: 217–221. https://doi.org/10.33588/rn.7908.2024117.

  • [7]Kukkle PL, Garg D, Merello M. Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson’s Disease: A Systematic Review. Movement Disorders Clinical Practice. 2023; 10: 1253–1267. https://doi.org/10.1002/mdc3.13810.

  • [8]Vivancos-Matellano F, Garcia-Ruiz AJ, Garcia-Agua Soler N. Pharmacoeconomic study of the treatment of advanced Parkinson’s disease. Revista De Neurologia. 2016; 63: 529–536.

  • [9]Instituto Nacional de Estadística (INE). Índice de Precios de Consumo Base 2021: Sanidad. Madrid: INE; 2024. Disponible en: https://www.ine.es/consul/ (Accedido: 28 Febrero 2025).

  • [10]Vallejo-Torres L. Estimating the Incremental Cost Per QALY Produced by the Spanish NHS: A Fixed-Effect Econometric Approach. PharmacoEconomics. 2025; 43: 109–122. https://doi.org/10.1007/s40273-024-01441-4.

Academic Editor

Article Metrics

  • Information

  • Download

  • Contents

Open Access 26 Feb 2026Letter to the Editor
EnglishSpanish
Continuous Subcutaneous Apomorphine Infusion Therapy: Economic Impact in Spain
Lina Micolta-Córdoba 1,*, Juan Pablo Castro-Ramirez 2, Carlos Reyes-Ortiz 3
Affiliations
Article Info

1 Residente Geriatría, Facultad de la Salud, Universidad del Valle, 760043 Santiago de Cali, Colombia

2 Departamento de Clínicas Médicas, Facultad de Ciencias de la Salud, Pontificia Universidad Javeriana, 720001 Cali, Colombia

3 Institute of Public Health, College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA

*Correspondence: linamicolta1712@gmail.com (Lina Micolta-Córdoba)

References

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.